According to the US Centers for Disease Control and Prevention (CDC), patients with
underlying health conditions, including all types of lung and cardiovascular diseases, have an …

Atrial septal defects (ASD) are a common congenital heart defect. The majority of patient
with ASDs often follow an uncomplicated course of events. However, a proportion of patients …

Objectives Approximately 5%–10% of adults with congenital heart disease (CHD) develop
pulmonary arterial hypertension (PAH), which affects life expectancy and quality of life. …

Congenital heart disease (CHD) is the most common inborn defect. Due to advances in
paediatric care, surgical, and catheter procedures the number of adults with CHD has grown …

Background COVID-19 has caused significant worldwide morbidity and mortality. Congenital
heart disease (CHD) is likely to increase vulnerability and understanding the predictors of …

Background Patients with adult congenital heart disease (ACHD) are a rapidly growing
cardiovascular population with increasing health needs and co-morbidities. Furthermore, their …

Background Pulmonary arterial hypertension (PAH), is a rare and progressive disease with
a high morbidity and mortality. Prostanoid pulmonary vasodilators are the most effective …

… Brida, Margarita a,b,c ; Nashat, Heba a,b ; Gatzoulis, Michael A. a,b … Nashat H, Brida M,
Price LS, et al. Pulmonary arterial hypertension complicating congenital heart disease …

Eisenmenger syndrome (ES) is the most severe form of pulmonary arterial hypertension (PAH)
related to congenital heart disease (CHD). It results from a cardiac defect allowing …

Objective To describe the intervention spectrum, complexity, and safety outcomes of catheter-based
interventions in a contemporary adult congenital heart disease (ACHD) tertiary …